Alterations in adult behavioral responses to cocaine and dopamine transporters following juvenile exposure to methamphetamine

Behavioural Brain Research

Volumn 216, Issue 2, 2011, Pages 726-730

  McFadden, Lisa ^a,c   Yamamoto, Bryan K ^b   Matuszewich, Leslie ^a  

^a NORTHERN ILLINOIS UNIVERSITY   (United States)

^b UNIVERSITY OF TOLEDO   (United States)

^c UNIVERSITY OF UTAH   (United States)

Author keywords

Cocaine; Juvenile; Methamphetamine; Rat; Sex differences; Striatum

Indexed keywords

COCAINE; DOPAMINE TRANSPORTER; METHAMPHETAMINE;

ARTICLE; BEHAVIOR; BRAIN FUNCTION; COGNITION; CORPUS STRIATUM; DOPAMINERGIC SYSTEM; DRUG ABUSE; DRUG EXPOSURE; ENVIRONMENTAL EXPOSURE; IMMUNOREACTIVITY; JUVENILE; NONHUMAN; PERINATAL DRUG EXPOSURE; PRIORITY JOURNAL; SEX DIFFERENCE;

AGE FACTORS; ANIMALS; BEHAVIOR, ANIMAL; COCAINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DOPAMINE UPTAKE INHIBITORS; DRUG SYNERGISM; EXPLORATORY BEHAVIOR; FEMALE; MALE; METHAMPHETAMINE; NEOSTRIATUM; RATS; SEX FACTORS; SUBSTANCE-RELATED DISORDERS; TIME FACTORS;

EID: 78149497935     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2010.08.041     Document Type: Article

References (32)

1. Almqvist P.M., Akesson E., Wahlberg L.U., Pschera H., Seiger A., Sundstrom E. First trimester development of the human nigrostriatal dopamine system. Exp Neurol 1996, 139(2):227-237.
2. Andersen S.L. Trajectories of brain development: point of vulnerability or window of opportunity. Neurosci Biobehav Rev 2003, 27(1-2):3-18.
3. Andersen S.L., Arvanitogiannis A., Pliakas A.M., LeBlanc C., Carlezon W.A. Altered responsiveness to cocaine in rats exposed to methylphenidate during development. Nat Neurosci 2002, 5(1):13-14.
4. Andersen S.L., Rutstein M., Benzo J.M., Hostetter J.C., Teicher M.H. Sex differences in dopamine receptor overproduction and elimination. Neuroreport 1997, 8(6):1495-1498.
5. Becker J.B., Hu M. Sex differences in drug abuse. Front Neuroendocrinol 2008, 29(1):36-47.
6. Cailhol S., Mormède P. Strain and sex differences in the locomotor response and behavioral sensitization to cocaine in hyperactive rats. Brain Res 1999, 842(1):200-205.
7. Caldicott D.G., Pigou P.E., Beattie R., Edwards J.W. Clandestine drug laboratories in Australia and the potential for harm. Aust Nz J Publ Health 2005, 29(2):155-162.
8. Carlezon W.A., Mague S.D., Andersen S.L. Enduring behavioral effects of early exposure to methylphenidate in rats. Biol Psychiatry 2003, 54(12):1330-1337.
9. Chang L., Smith L.M., LoPresti C., Yonekura M.L., Kuo J., Walot I., et al. Smaller subcortical volumes and cognitive deficits in children with prenatal methamphetamine exposure. Psychiatry Res 2004, 132(2):95-106.
10. Chomchai C., Na Manorom N., Watanarungsan P., Yossuck P., Chomchai S. Methamphetamine abuse during pregnancy and its health impact on neonates born at Siriraj Hospital, Bangkok Thailand. Southeast Asian J Trop Med Public Health 2004, 35(1):228-231.
11. Crawford C.A., Williams M.T., Newman E.R., McDougall S.A., Vorhees C.V. Methamphetamine exposure during the preweanling period causes prolonged changes in dorsal striatal protein kinase A activity, dopamine D2-like binding sites, and dopamine content. Synapse 2003, 48(3):131-137.
12. Crits-Christoph P., Newberg A., Wintering N., Ploessl K., Gibbons M.B., Ring-Kurtz S., et al. Dopamine transporter levels in cocaine dependent subjects. Drug Alcohol Depend 2008, 98(1-2):70-76.
13. Dopheide J.A., Pliszka S.R. Attention-deficit-hyperactivity disorder: an update. Pharmacotherapy 2009, 29(6):656-679.
14. Fleckenstein A.E., Volz T.J., Riddle E.L., Gibb J.W., Hanson G.R. New insights into the mechanism of action of amphetamines. Annu Rev Pharmacol Toxicol 2007, 47:681-698.
15. Giedd J.N., Snell J.W., Lange N., Rajapakse J.C., Casey B.J., Kozuch P.L., et al. Quantitative magnetic resonance imaging of human brain development: ages 4-18. Cereb Cortex 1996, 6(4):551-560.
16. Haile C.N., GrandPre T., Kosten T.A. Chronic unpredictable stress, but not chronic predictable stress, enhances the sensitivity to the behavioral effects of cocaine in rats. Psychopharmacology (Berl) 2001, 154(2):213-220.
17. Haycock J.W., Becker L., Ang L., Furukawa Y., Hornykiewicz O., Kish S.J. Marked disparity between age-related changes in dopamine and other presynaptic dopaminergic markers in human striatum. J Neurochem 2003, 87(3):574-585.
18. Herlenius E., Lagercrantz H. Neurotransmitters and neuromodulators during early human development. Early Hum Dev 2001, 65(1):21-37.
19. Hser Y.I., Longshore D., Anglin M.D. The life course perspective on drug use: a conceptual framework for understanding drug use trajectories. Eval Rev 2007, 31(6):515-547.
20. Jucaite A., Forssberg H., Karlsson P., Halldin C., Farde L. Age-related reduction in dopamine D1 receptors in the human brain: from late childhood to adulthood, a positron emission tomography study. Neuroscience 2010, 167(1):104-110.
21. Kuhn C.M., Walker Q.D., Kaplan K.A., Li S.T. Sex, steroids, and stimulant sensitivity. Ann NY Acad Sci 2001, 937:188-201.
22. Marazziti D., Mandillo S., Di Pietro C., Golini E., Matteoni R. Tocchini-Valentini GP. GPR37 associates with the dopamine transporter to modulate dopamine uptake and behavioral responses to dopaminergic drugs. Proc Natl Acad Sci USA 2007, 104(23):9846-9851.
23. McFadden L.M., Matuszewich L. The effects of methamphetamine exposure during preadolescence on male and female rats in the water maze. Behav Brain Res 2007, 185(2):99-109.
24. Mecham N., Melini J. Unintentional victims: development of a protocol for the care of children exposed to chemicals at methamphetamine laboratories. Pediatr Emerg Care 2002, 18(4):327-332.
25. Moll G.H., Mehnert C., Wicker M., Bock N., Rothenberger A., Rüther E., et al. Age-associated changes in the densities of presynaptic monoamine transporters in different regions of the rat brain from early juvenile life to late adulthood. Brain Res Dev Brain Res 2000, 119(2):251-257.
26. Morissette M., Di Paolo T. Sex and estrous cycle variations of rat striatal dopamine uptake sites. Neuroendocrinology 1993, 58(1):16-22.
27. Quinton M.S., Yamamoto B.K. Neurotoxic effects of chronic restraint stress in the striatum of methamphetamine-exposed rats. Psychopharmacology 2007, 193(3):341-350.
28. Smith L.M., Chang L., Yonekura M.L., Grob C., Osborn D., Ernst T. Brain proton magnetic resonance spectroscopy in children exposed to methamphetamine in utero. Neurology 2001, 57(2):255-260.
29. Spencer T.J., Biederman J., Madras B.K., Dougherty D.D., Bonab A.A., Livni E., et al. Further evidence of dopamine transporter dysregulation in ADHD: a controlled PET imaging study using altropane. Biol Psychiatry 2007, 62(9):1059-1061.
30. Tilley M.R., Cagniard B., Zhuang X., Han D.D., Tiao N., Gu H.H. Cocaine reward and locomotion stimulation in mice with reduced dopamine transporter expression. BMC Neurosci 2007, 8:42.
31. Walker Q.D., Nelson C.J., Smith D., Kuhn, CM Vaginal lavage attenuates cocaine-stimulated activity and establishes place preference in rats. Pharmacol Biochem Behav 2002, 73(4):743-752.
32. Watanabe Y., Fujita M., Ito Y., Okada T., Kusuoka H., Nishimura T. Brain dopamine transporter in spontaneously hypertensive rats. J Nucl Med 1997, 38(3):470-474.